NRX Pharmaceuticals, Inc. Notes Payable
NRX Pharmaceuticals, Inc. (NRXP) had Notes Payable of $1.69 million as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:NotesPayable · last filed 2020-11-16
- 2020-09-30: Notes Payable $1.69M.
- 2020-06-30: Notes Payable $1.67M.
- 2020-03-31: Notes Payable $1.63M.
- 2019-12-31: Notes Payable $1.54M.
| Period end | Notes Payable |
|---|---|
| 2020-09-30 | $1.69M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.67M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.63M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $1.54M 10-Q · filed 2020-11-16 |
| 2019-09-30 | $1.46M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.38M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.49M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $690.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |